BCG vaccination induces antibacterial effector functions among Vdelta1/3 T cells that are associated with protection against tuberculosis

Read full text Summarise with VIRAT
Authors: Megan D. Maerz
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Gamma delta T cells expressing a Vdelta1/3 T cell receptor are enriched at mucosal surfaces, but their role in protection against Mycobacterium tuberculosis is largely unknown. We used multimodal single-cell RNA sequencing, mass cytometry, and flow cytometry to profile gamma delta T cells from human infants and macaques after protective vaccination with Mycobacterium bovis bacillus Calmette-Guerin. A subset of Vdelta1/3 T cells in BCG-vaccinated human infants shows evidence of clonal expansion and differentiation into Mtb-reactive cytotoxic effector cells. In macaques, intravenous BCG induces pro-inflammatory and cytotoxic responses to Mtb among Vdelta1/3 T cells that are enriched in the airway compared to the blood. Finally, the frequency of cytokine-expressing Vdelta1/3 T cells in the airway is associated with protection against Mtb challenge. Thus, Vdelta1/3 T cells are activated by BCG and accumulate in the lung, where they upregulate cytotoxic and pro-inflammatory functions that may contribute to protective immunity against Mtb.

Fields of Study & Subjects

Tuberculosis Research and Epidemiology T-cell and B-cell Immunology Immune responses and vaccinations

Publication details

Journal / source
ImmPort
Publication date
26 March 2026
Language
EN
Document type
Dataset